Roche’s Analyst Event from SABCS 2019

Live Audio Webcast and Conference Call
Monday, 16 December 2019 at 15:30 CET

Additional information

Invitation

Related links

Investor updates

All

Published on: 13 December 2019

Roche announces positive Phase III study results for Tecentriq plus Cotellic and Zelboraf in people with previously untreated BRAF V600 mutation-positive advanced melanoma

more

Published on: 12 December 2019

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin comparable to intravenous formulations in people with HER2-positive breast cancer

more

Published on: 11 December 2019

APHINITY six-year results strengthen evidence of clinical benefit with Roche’s Perjeta-based regimen

more

IR events

All

16December

Roche’s live audio webcast and conference call on key data presented at SABCS 2019

(PDT)

Texas, US

more add to calendar

14January

J.P. Morgan 38th Annual Healthcare Conference

(PST)

San Francisco, US

add to calendar

16January

Octavian Seminar 2020

(CET)

Zurich, Switzerland

add to calendar

Share price

Latest annual report

Annual Report 2018 Highlights

How digital innovation increases patient benefit in the future

more

Finance information tool

more

Pipeline

Pipeline

Get up-to-date information about our pipeline.

more

Roche R&D

more

Genentech Biooncology

more

Diagnostics

Diagnostics overview

Get an introduction to our Diagnostics business.

more

Sustainability

Sustainability download center

more

Sustainability at Roche

more

Non-financial reporting

more

Dividend and total return

Dividend calendar

Timetable for payment of the 2018 dividend

more

Total return center

Investor tool providing analysis of total returns

more

Frequently asked questions

FAQ

Get answers to frequently asked questions

more

US investors

How to invest

more

poster

Message from our CEO

“The foundation of our success is and will remain our clear focus on innovation.”

Contact